| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 1, Human | 105 | 2024 | 743 | 17.990 |
Why?
|
| Herpes Simplex | 49 | 2024 | 470 | 8.870 |
Why?
|
| Simplexvirus | 79 | 2015 | 802 | 7.460 |
Why?
|
| Immediate-Early Proteins | 44 | 2024 | 453 | 6.880 |
Why?
|
| Virus Replication | 87 | 2024 | 2534 | 6.340 |
Why?
|
| Viral Proteins | 95 | 2022 | 1900 | 6.320 |
Why?
|
| Gene Expression Regulation, Viral | 39 | 2024 | 442 | 5.910 |
Why?
|
| Herpesvirus 2, Human | 29 | 2021 | 189 | 5.420 |
Why?
|
| Virus Latency | 31 | 2021 | 358 | 4.090 |
Why?
|
| DNA, Viral | 46 | 2022 | 2225 | 4.030 |
Why?
|
| Herpes Genitalis | 17 | 2021 | 141 | 3.670 |
Why?
|
| Host-Pathogen Interactions | 22 | 2021 | 1477 | 3.140 |
Why?
|
| Genes, Immediate-Early | 6 | 2021 | 101 | 2.430 |
Why?
|
| Heterochromatin | 11 | 2023 | 296 | 2.420 |
Why?
|
| Vero Cells | 56 | 2018 | 485 | 2.330 |
Why?
|
| Genome, Viral | 16 | 2023 | 667 | 2.300 |
Why?
|
| Herpesvirus Vaccines | 6 | 2017 | 11 | 2.130 |
Why?
|
| Cell Nucleus | 33 | 2022 | 2969 | 2.040 |
Why?
|
| Phosphoproteins | 10 | 2023 | 2440 | 2.010 |
Why?
|
| Ubiquitin-Protein Ligases | 16 | 2023 | 1861 | 1.960 |
Why?
|
| Nuclear Proteins | 16 | 2023 | 5853 | 1.830 |
Why?
|
| Genes, Viral | 32 | 2019 | 718 | 1.810 |
Why?
|
| Herpesviridae | 5 | 2019 | 109 | 1.790 |
Why?
|
| Defective Viruses | 10 | 2007 | 112 | 1.560 |
Why?
|
| Viral Vaccines | 12 | 2021 | 636 | 1.550 |
Why?
|
| Herpes Simplex Virus Vaccines | 7 | 2019 | 18 | 1.540 |
Why?
|
| Cell Line | 71 | 2021 | 15997 | 1.440 |
Why?
|
| DNA Viruses | 4 | 2022 | 36 | 1.280 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 5 | 2015 | 28 | 1.250 |
Why?
|
| Epigenesis, Genetic | 10 | 2024 | 3647 | 1.210 |
Why?
|
| Immunity, Innate | 12 | 2021 | 2958 | 1.190 |
Why?
|
| DNA Replication | 33 | 2018 | 1399 | 1.180 |
Why?
|
| Fibroblasts | 12 | 2021 | 4161 | 1.170 |
Why?
|
| Chromatin | 9 | 2018 | 2934 | 1.170 |
Why?
|
| Genetic Vectors | 13 | 2021 | 3420 | 1.130 |
Why?
|
| Viruses | 6 | 2023 | 374 | 1.130 |
Why?
|
| Gene Silencing | 9 | 2021 | 1538 | 1.120 |
Why?
|
| DNA-Binding Proteins | 44 | 2015 | 9648 | 1.110 |
Why?
|
| Trigeminal Ganglion | 18 | 2019 | 186 | 0.950 |
Why?
|
| Herpesviridae Infections | 2 | 2024 | 277 | 0.950 |
Why?
|
| Promoter Regions, Genetic | 12 | 2016 | 5867 | 0.920 |
Why?
|
| Interferon Regulatory Factor-3 | 4 | 2017 | 123 | 0.890 |
Why?
|
| Virus Activation | 12 | 2018 | 319 | 0.870 |
Why?
|
| Immune Evasion | 6 | 2021 | 360 | 0.850 |
Why?
|
| Animals | 171 | 2024 | 168757 | 0.820 |
Why?
|
| Transcription, Genetic | 20 | 2018 | 7722 | 0.820 |
Why?
|
| Lamin Type A | 4 | 2015 | 190 | 0.810 |
Why?
|
| Interferon Type I | 8 | 2021 | 542 | 0.810 |
Why?
|
| Antiviral Agents | 9 | 2023 | 2987 | 0.790 |
Why?
|
| Viral Envelope Proteins | 14 | 2021 | 635 | 0.790 |
Why?
|
| TNF Receptor-Associated Factor 6 | 2 | 2013 | 55 | 0.770 |
Why?
|
| Nucleotidyltransferases | 3 | 2023 | 220 | 0.750 |
Why?
|
| Vaccines, Virus-Like Particle | 2 | 2021 | 40 | 0.750 |
Why?
|
| Toll-Like Receptor 2 | 8 | 2013 | 354 | 0.740 |
Why?
|
| RNA, Viral | 20 | 2021 | 2902 | 0.710 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2021 | 298 | 0.710 |
Why?
|
| Bacteriophages | 1 | 2022 | 356 | 0.690 |
Why?
|
| Proviruses | 1 | 2021 | 318 | 0.680 |
Why?
|
| Immunization | 11 | 2019 | 1256 | 0.660 |
Why?
|
| Viral Structural Proteins | 5 | 2016 | 103 | 0.650 |
Why?
|
| Cytomegalovirus | 6 | 2017 | 732 | 0.640 |
Why?
|
| Active Transport, Cell Nucleus | 5 | 2019 | 443 | 0.610 |
Why?
|
| Ribonucleases | 3 | 2016 | 287 | 0.610 |
Why?
|
| Ganglia | 2 | 2015 | 89 | 0.590 |
Why?
|
| Antibodies, Viral | 20 | 2021 | 3176 | 0.580 |
Why?
|
| Mice, Inbred BALB C | 23 | 2017 | 6386 | 0.580 |
Why?
|
| Keratitis, Herpetic | 6 | 2007 | 81 | 0.570 |
Why?
|
| West Nile virus | 1 | 2016 | 82 | 0.540 |
Why?
|
| Mice | 83 | 2024 | 81183 | 0.540 |
Why?
|
| Histones | 7 | 2021 | 2599 | 0.540 |
Why?
|
| Signal Transduction | 15 | 2021 | 23403 | 0.530 |
Why?
|
| Host Cell Factor C1 | 1 | 2015 | 31 | 0.530 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2015 | 54 | 0.520 |
Why?
|
| RNA Viruses | 2 | 2014 | 124 | 0.520 |
Why?
|
| Antibodies, Neutralizing | 4 | 2021 | 1978 | 0.510 |
Why?
|
| Interferon-beta | 3 | 2017 | 323 | 0.500 |
Why?
|
| DNA Virus Infections | 1 | 2014 | 13 | 0.500 |
Why?
|
| Vaccines, Attenuated | 7 | 2017 | 342 | 0.480 |
Why?
|
| Mutation | 51 | 2019 | 29786 | 0.480 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2015 | 171 | 0.470 |
Why?
|
| Simian virus 40 | 2 | 2013 | 295 | 0.470 |
Why?
|
| Virus Diseases | 3 | 2023 | 711 | 0.470 |
Why?
|
| Ebolavirus | 2 | 2022 | 263 | 0.460 |
Why?
|
| Protein Multimerization | 1 | 2019 | 970 | 0.460 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2015 | 157 | 0.450 |
Why?
|
| Herpes Labialis | 1 | 2012 | 29 | 0.440 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2014 | 142 | 0.420 |
Why?
|
| Cations, Divalent | 1 | 2012 | 166 | 0.420 |
Why?
|
| Transfection | 20 | 2015 | 5892 | 0.410 |
Why?
|
| RNA, Messenger | 24 | 2009 | 13033 | 0.410 |
Why?
|
| Humans | 121 | 2024 | 744343 | 0.410 |
Why?
|
| Osteosarcoma | 3 | 2015 | 881 | 0.410 |
Why?
|
| DNA Damage | 2 | 2021 | 2432 | 0.400 |
Why?
|
| Cytoplasm | 8 | 2015 | 1539 | 0.390 |
Why?
|
| Recombination, Genetic | 8 | 2015 | 1586 | 0.390 |
Why?
|
| Capsid Proteins | 4 | 2019 | 479 | 0.390 |
Why?
|
| Complement C3 | 3 | 2008 | 461 | 0.380 |
Why?
|
| AIDS Vaccines | 2 | 2009 | 938 | 0.380 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 670 | 0.380 |
Why?
|
| Cells, Cultured | 19 | 2021 | 19229 | 0.380 |
Why?
|
| Down-Regulation | 2 | 2016 | 3002 | 0.380 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 2916 | 0.380 |
Why?
|
| Immunoprecipitation | 5 | 2015 | 905 | 0.370 |
Why?
|
| Gene Deletion | 7 | 2007 | 2751 | 0.370 |
Why?
|
| HEK293 Cells | 8 | 2021 | 4204 | 0.370 |
Why?
|
| Repressor Proteins | 2 | 2021 | 3023 | 0.360 |
Why?
|
| HIV | 2 | 2017 | 1604 | 0.360 |
Why?
|
| Receptors, Complement 3d | 2 | 2008 | 118 | 0.360 |
Why?
|
| Proteome | 3 | 2015 | 1799 | 0.360 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 428 | 0.360 |
Why?
|
| Fluorescent Antibody Technique | 14 | 2015 | 2505 | 0.350 |
Why?
|
| Base Sequence | 20 | 2019 | 12797 | 0.340 |
Why?
|
| Virulence Factors | 1 | 2013 | 509 | 0.340 |
Why?
|
| DNA Helicases | 6 | 2016 | 859 | 0.330 |
Why?
|
| Cell Fusion | 4 | 2021 | 297 | 0.320 |
Why?
|
| Amino Acid Sequence | 14 | 2021 | 13815 | 0.320 |
Why?
|
| Molecular Sequence Data | 18 | 2015 | 18111 | 0.310 |
Why?
|
| Adenosine Triphosphatases | 2 | 2016 | 839 | 0.310 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 4 | 2013 | 428 | 0.310 |
Why?
|
| Plasmids | 13 | 2013 | 2307 | 0.310 |
Why?
|
| Green Fluorescent Proteins | 3 | 2009 | 2088 | 0.300 |
Why?
|
| NF-kappa B | 4 | 2018 | 2499 | 0.300 |
Why?
|
| Gene Expression | 9 | 2024 | 7799 | 0.290 |
Why?
|
| Thymidine Kinase | 9 | 2003 | 290 | 0.290 |
Why?
|
| Trans-Activators | 4 | 2024 | 2924 | 0.280 |
Why?
|
| Encephalitis, Viral | 3 | 2004 | 55 | 0.280 |
Why?
|
| HeLa Cells | 6 | 2018 | 3128 | 0.280 |
Why?
|
| Receptors, Complement 3b | 1 | 2006 | 145 | 0.280 |
Why?
|
| MicroRNAs | 6 | 2024 | 3752 | 0.280 |
Why?
|
| Cell Transformation, Viral | 7 | 2000 | 565 | 0.270 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2006 | 147 | 0.270 |
Why?
|
| Virus Physiological Phenomena | 2 | 2021 | 18 | 0.270 |
Why?
|
| Genes, Reporter | 2 | 2010 | 1547 | 0.260 |
Why?
|
| RNA, Small Interfering | 5 | 2018 | 3505 | 0.260 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2011 | 736 | 0.260 |
Why?
|
| Receptor, Interferon alpha-beta | 3 | 2017 | 107 | 0.260 |
Why?
|
| Vesicular stomatitis Indiana virus | 8 | 1978 | 94 | 0.260 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2013 | 635 | 0.260 |
Why?
|
| Sendai virus | 1 | 2004 | 21 | 0.250 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2004 | 92 | 0.250 |
Why?
|
| Genetic Engineering | 2 | 2019 | 951 | 0.250 |
Why?
|
| Disease Models, Animal | 17 | 2019 | 18029 | 0.250 |
Why?
|
| Immunity, Cellular | 4 | 2018 | 1607 | 0.240 |
Why?
|
| Viral Fusion Proteins | 3 | 2005 | 95 | 0.240 |
Why?
|
| Gene Expression Regulation | 10 | 2019 | 12072 | 0.240 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 3798 | 0.240 |
Why?
|
| DNA-Directed DNA Polymerase | 3 | 1998 | 486 | 0.230 |
Why?
|
| Interferons | 4 | 2023 | 706 | 0.230 |
Why?
|
| Vaccines, Synthetic | 3 | 2001 | 634 | 0.230 |
Why?
|
| Blotting, Western | 8 | 2013 | 5179 | 0.230 |
Why?
|
| Exodeoxyribonucleases | 3 | 2004 | 180 | 0.230 |
Why?
|
| Binding Sites | 8 | 2018 | 6114 | 0.230 |
Why?
|
| Vesiculovirus | 2 | 2021 | 50 | 0.230 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 473 | 0.230 |
Why?
|
| Immunoblotting | 3 | 2015 | 1682 | 0.220 |
Why?
|
| Virology | 1 | 2023 | 77 | 0.220 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2529 | 0.220 |
Why?
|
| Protein Interaction Mapping | 2 | 2016 | 627 | 0.220 |
Why?
|
| DNA Repair | 2 | 2019 | 2046 | 0.220 |
Why?
|
| Protein Biosynthesis | 4 | 2008 | 2126 | 0.210 |
Why?
|
| Sequence Deletion | 4 | 2011 | 1526 | 0.210 |
Why?
|
| G1 Phase | 2 | 2001 | 415 | 0.210 |
Why?
|
| Antibody Formation | 2 | 2006 | 1402 | 0.210 |
Why?
|
| CD8-Positive T-Lymphocytes | 8 | 2023 | 4479 | 0.210 |
Why?
|
| Orthobunyavirus | 1 | 2021 | 1 | 0.210 |
Why?
|
| Bunyaviridae Infections | 1 | 2021 | 2 | 0.210 |
Why?
|
| Keratinocytes | 2 | 2017 | 798 | 0.210 |
Why?
|
| Epithelial Cells | 3 | 2022 | 3690 | 0.210 |
Why?
|
| Phosphorylation | 10 | 2021 | 8436 | 0.200 |
Why?
|
| Eukaryota | 1 | 2022 | 99 | 0.200 |
Why?
|
| Eukaryotic Cells | 1 | 2022 | 198 | 0.200 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 669 | 0.200 |
Why?
|
| Foreskin | 1 | 2021 | 31 | 0.200 |
Why?
|
| Interferon-gamma | 7 | 2023 | 3206 | 0.190 |
Why?
|
| Chemokines | 2 | 2005 | 970 | 0.190 |
Why?
|
| Mutagenesis | 3 | 2019 | 1266 | 0.190 |
Why?
|
| Genetic Testing | 1 | 2014 | 3444 | 0.190 |
Why?
|
| Animal Experimentation | 1 | 2020 | 45 | 0.190 |
Why?
|
| Vaccines, DNA | 3 | 2008 | 305 | 0.190 |
Why?
|
| STAT1 Transcription Factor | 3 | 2017 | 320 | 0.190 |
Why?
|
| Toll-Like Receptors | 5 | 2014 | 592 | 0.180 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 307 | 0.180 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2021 | 157 | 0.180 |
Why?
|
| Orthomyxoviridae | 1 | 2021 | 156 | 0.180 |
Why?
|
| DNA | 4 | 2023 | 7301 | 0.180 |
Why?
|
| Retinal Ganglion Cells | 1 | 2005 | 770 | 0.180 |
Why?
|
| Genetic Variation | 1 | 2015 | 6544 | 0.180 |
Why?
|
| Genetic Complementation Test | 6 | 1998 | 562 | 0.180 |
Why?
|
| Membrane Glycoproteins | 5 | 2014 | 3768 | 0.170 |
Why?
|
| Immunologic Memory | 3 | 2021 | 1348 | 0.170 |
Why?
|
| MART-1 Antigen | 1 | 2019 | 64 | 0.170 |
Why?
|
| Viremia | 2 | 2019 | 736 | 0.170 |
Why?
|
| Dendritic Cells | 4 | 2015 | 2725 | 0.170 |
Why?
|
| Immunoglobulin G | 7 | 2019 | 4560 | 0.170 |
Why?
|
| SAIDS Vaccines | 3 | 2006 | 166 | 0.170 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2018 | 55 | 0.170 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2021 | 248 | 0.170 |
Why?
|
| Protein Binding | 5 | 2021 | 9386 | 0.160 |
Why?
|
| Models, Genetic | 2 | 2019 | 3494 | 0.160 |
Why?
|
| Injections, Intramuscular | 3 | 2017 | 552 | 0.160 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 222 | 0.160 |
Why?
|
| Transcription Factors | 5 | 2024 | 12208 | 0.160 |
Why?
|
| Capsid | 4 | 2016 | 436 | 0.160 |
Why?
|
| Th1 Cells | 3 | 2018 | 1057 | 0.160 |
Why?
|
| Cytokines | 6 | 2021 | 7322 | 0.160 |
Why?
|
| Antigens, Viral | 5 | 2021 | 1035 | 0.160 |
Why?
|
| Proteomics | 3 | 2015 | 3638 | 0.160 |
Why?
|
| RNA Polymerase II | 1 | 2002 | 551 | 0.160 |
Why?
|
| DNA, Bacterial | 2 | 2022 | 1465 | 0.150 |
Why?
|
| RNA Precursors | 1 | 2019 | 208 | 0.150 |
Why?
|
| Cell Line, Tumor | 7 | 2020 | 16689 | 0.150 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2018 | 143 | 0.150 |
Why?
|
| Receptors, Interferon | 1 | 2017 | 115 | 0.150 |
Why?
|
| Conserved Sequence | 2 | 2012 | 1202 | 0.150 |
Why?
|
| Co-Repressor Proteins | 1 | 2018 | 194 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 14 | 2021 | 21827 | 0.150 |
Why?
|
| Neurons | 6 | 2024 | 9338 | 0.150 |
Why?
|
| Nuclear Lamina | 3 | 2009 | 46 | 0.150 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 893 | 0.150 |
Why?
|
| RNA Interference | 2 | 2018 | 2889 | 0.150 |
Why?
|
| Cell Compartmentation | 4 | 2003 | 402 | 0.150 |
Why?
|
| Cell Line, Transformed | 3 | 2008 | 898 | 0.150 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2015 | 1801 | 0.140 |
Why?
|
| Time Factors | 12 | 2015 | 40075 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 3 | 2014 | 2699 | 0.140 |
Why?
|
| Peripheral Nervous System | 1 | 2017 | 150 | 0.140 |
Why?
|
| Gene Order | 1 | 2016 | 176 | 0.140 |
Why?
|
| Glycoproteins | 7 | 2015 | 2263 | 0.140 |
Why?
|
| Myeloid Cells | 3 | 2022 | 810 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 809 | 0.130 |
Why?
|
| Receptors, Immunologic | 1 | 2021 | 1423 | 0.130 |
Why?
|
| Parainfluenza Virus 3, Human | 1 | 2015 | 24 | 0.130 |
Why?
|
| Mice, Knockout | 8 | 2018 | 14557 | 0.130 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2020 | 1475 | 0.130 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 961 | 0.130 |
Why?
|
| Transgenes | 1 | 2019 | 1009 | 0.130 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2017 | 547 | 0.130 |
Why?
|
| Cell Cycle | 3 | 2000 | 2967 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3870 | 0.130 |
Why?
|
| Oncolytic Viruses | 1 | 2019 | 327 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2016 | 1990 | 0.120 |
Why?
|
| Disease Susceptibility | 3 | 2021 | 1782 | 0.120 |
Why?
|
| Open Reading Frames | 3 | 2013 | 810 | 0.120 |
Why?
|
| Serial Passage | 1 | 2013 | 23 | 0.120 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2014 | 115 | 0.120 |
Why?
|
| Transcriptional Activation | 3 | 2008 | 1783 | 0.120 |
Why?
|
| Vaccination | 5 | 2019 | 3278 | 0.120 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2014 | 62 | 0.120 |
Why?
|
| Research | 1 | 2023 | 1999 | 0.120 |
Why?
|
| Phylogeny | 2 | 2019 | 2803 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2006 | 3772 | 0.120 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2015 | 165 | 0.120 |
Why?
|
| Receptors, Cell Surface | 3 | 2012 | 2866 | 0.120 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 738 | 0.120 |
Why?
|
| Flow Cytometry | 3 | 2013 | 5974 | 0.120 |
Why?
|
| Heparitin Sulfate | 1 | 2015 | 225 | 0.120 |
Why?
|
| Genes | 5 | 1989 | 1893 | 0.120 |
Why?
|
| Gene Targeting | 3 | 2019 | 880 | 0.120 |
Why?
|
| Microscopy | 1 | 2019 | 903 | 0.110 |
Why?
|
| Blotting, Northern | 2 | 2019 | 1581 | 0.110 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 742 | 0.110 |
Why?
|
| Virus Assembly | 2 | 2005 | 144 | 0.110 |
Why?
|
| Bacteria | 2 | 2022 | 2114 | 0.110 |
Why?
|
| Mammalian orthoreovirus 3 | 2 | 2002 | 44 | 0.110 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 503 | 0.110 |
Why?
|
| Liposomes | 2 | 2015 | 759 | 0.110 |
Why?
|
| Genes, Regulator | 2 | 1993 | 378 | 0.110 |
Why?
|
| Guinea Pigs | 5 | 2014 | 1386 | 0.110 |
Why?
|
| Reoviridae Infections | 2 | 2002 | 60 | 0.110 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2014 | 262 | 0.110 |
Why?
|
| Geography | 1 | 2015 | 669 | 0.110 |
Why?
|
| Interleukin-2 | 1 | 2020 | 1904 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 587 | 0.110 |
Why?
|
| RNA-Binding Proteins | 2 | 2019 | 1903 | 0.110 |
Why?
|
| United States Food and Drug Administration | 1 | 2020 | 1584 | 0.110 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 1736 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2014 | 500 | 0.110 |
Why?
|
| Herpesvirus 8, Human | 1 | 2014 | 258 | 0.110 |
Why?
|
| Polyethyleneimine | 1 | 2012 | 63 | 0.110 |
Why?
|
| Virion | 2 | 2006 | 433 | 0.110 |
Why?
|
| Monocytes | 1 | 2022 | 2596 | 0.100 |
Why?
|
| Cancer Vaccines | 2 | 2020 | 1023 | 0.100 |
Why?
|
| Complement System Proteins | 3 | 2006 | 795 | 0.100 |
Why?
|
| Cytomegalovirus Infections | 3 | 2017 | 820 | 0.100 |
Why?
|
| Genetic Markers | 3 | 2015 | 2634 | 0.100 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 2645 | 0.100 |
Why?
|
| Vagina | 5 | 2014 | 825 | 0.100 |
Why?
|
| Neutralization Tests | 2 | 2007 | 758 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 4 | 2014 | 6171 | 0.100 |
Why?
|
| Sensory Receptor Cells | 1 | 2016 | 492 | 0.100 |
Why?
|
| Interleukin-17 | 1 | 2017 | 899 | 0.100 |
Why?
|
| beta-Galactosidase | 4 | 2002 | 573 | 0.100 |
Why?
|
| Melanoma | 3 | 2020 | 5510 | 0.100 |
Why?
|
| Neurons, Afferent | 3 | 2003 | 506 | 0.100 |
Why?
|
| Epitopes | 2 | 2011 | 2571 | 0.100 |
Why?
|
| In Situ Hybridization | 5 | 2000 | 1950 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2019 | 1881 | 0.100 |
Why?
|
| Biological Transport | 4 | 2005 | 2118 | 0.100 |
Why?
|
| Male | 24 | 2024 | 350118 | 0.090 |
Why?
|
| Antigens, CD1d | 1 | 2011 | 220 | 0.090 |
Why?
|
| Urine | 1 | 2012 | 370 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 4803 | 0.090 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 853 | 0.090 |
Why?
|
| Rabbits | 4 | 2014 | 4894 | 0.090 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2010 | 168 | 0.090 |
Why?
|
| Janus Kinase 1 | 1 | 2009 | 104 | 0.090 |
Why?
|
| Female | 30 | 2021 | 380194 | 0.090 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 936 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 560 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1997 | 1838 | 0.090 |
Why?
|
| Peptides | 4 | 2020 | 4409 | 0.090 |
Why?
|
| Immunogenetics | 1 | 2009 | 67 | 0.090 |
Why?
|
| Viral Load | 5 | 2019 | 3299 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4554 | 0.080 |
Why?
|
| Acetylation | 2 | 2009 | 1085 | 0.080 |
Why?
|
| Skin | 2 | 2021 | 4364 | 0.080 |
Why?
|
| Telomere | 1 | 2014 | 910 | 0.080 |
Why?
|
| T-Lymphocytes | 5 | 2019 | 10180 | 0.080 |
Why?
|
| Simian immunodeficiency virus | 2 | 2006 | 846 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2013 | 1012 | 0.080 |
Why?
|
| Macrophages | 3 | 2016 | 5655 | 0.080 |
Why?
|
| Antigens, Surface | 1 | 2012 | 1663 | 0.080 |
Why?
|
| Phosphonoacetic Acid | 2 | 1996 | 55 | 0.080 |
Why?
|
| Molecular Mimicry | 1 | 2009 | 201 | 0.080 |
Why?
|
| Membrane Fusion | 2 | 2006 | 273 | 0.080 |
Why?
|
| Interleukin-8 | 2 | 2008 | 690 | 0.080 |
Why?
|
| Natural Killer T-Cells | 1 | 2011 | 316 | 0.080 |
Why?
|
| CDC2 Protein Kinase | 1 | 2009 | 220 | 0.080 |
Why?
|
| Ubiquitins | 1 | 2009 | 384 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 3846 | 0.080 |
Why?
|
| Trigeminal Nerve | 1 | 1989 | 249 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2012 | 2256 | 0.080 |
Why?
|
| Macaca mulatta | 3 | 2010 | 2375 | 0.070 |
Why?
|
| Antigen Presentation | 2 | 2011 | 1284 | 0.070 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 2026 | 0.070 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2001 | 671 | 0.070 |
Why?
|
| Leukemia | 1 | 2015 | 1511 | 0.070 |
Why?
|
| Mice, Inbred ICR | 2 | 2004 | 352 | 0.070 |
Why?
|
| Ouabain | 1 | 2007 | 264 | 0.070 |
Why?
|
| Virulence | 1 | 2011 | 1333 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2019 | 4386 | 0.070 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2007 | 129 | 0.070 |
Why?
|
| Leupeptins | 1 | 2006 | 122 | 0.070 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2015 | 1270 | 0.070 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 437 | 0.070 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2006 | 190 | 0.070 |
Why?
|
| Replicon | 1 | 2006 | 34 | 0.070 |
Why?
|
| Cell Membrane | 8 | 2014 | 3748 | 0.070 |
Why?
|
| Phenotype | 8 | 2021 | 16365 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 2005 | 1827 | 0.070 |
Why?
|
| Palmitic Acid | 1 | 2006 | 154 | 0.070 |
Why?
|
| Central Nervous System | 2 | 2011 | 1357 | 0.070 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2012 | 1877 | 0.070 |
Why?
|
| Cornea | 5 | 2004 | 1524 | 0.070 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2009 | 370 | 0.070 |
Why?
|
| Recombinant Proteins | 3 | 2020 | 6622 | 0.070 |
Why?
|
| Viral Regulatory and Accessory Proteins | 2 | 2006 | 159 | 0.070 |
Why?
|
| South Africa | 1 | 2011 | 1731 | 0.070 |
Why?
|
| Eye | 3 | 2003 | 729 | 0.070 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2005 | 73 | 0.070 |
Why?
|
| DNA Primase | 2 | 1996 | 109 | 0.070 |
Why?
|
| Temperature | 9 | 1986 | 2206 | 0.070 |
Why?
|
| Tritium | 2 | 2006 | 745 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2019 | 1836 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2022 | 1341 | 0.060 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 2004 | 36 | 0.060 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2006 | 1821 | 0.060 |
Why?
|
| RNA Splicing | 1 | 2009 | 907 | 0.060 |
Why?
|
| Papillomavirus Vaccines | 1 | 2011 | 491 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2004 | 49 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2004 | 68 | 0.060 |
Why?
|
| RecQ Helicases | 1 | 2004 | 54 | 0.060 |
Why?
|
| Spinal Cord | 2 | 2002 | 1809 | 0.060 |
Why?
|
| Lac Operon | 2 | 1997 | 238 | 0.060 |
Why?
|
| HIV-1 | 2 | 2019 | 6939 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2016 | 2203 | 0.060 |
Why?
|
| Antigens, Nuclear | 1 | 2004 | 192 | 0.060 |
Why?
|
| United States | 3 | 2020 | 69872 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1990 | 1375 | 0.060 |
Why?
|
| Interferon-alpha | 1 | 2008 | 895 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 1996 | 491 | 0.060 |
Why?
|
| Transplantation Chimera | 1 | 2006 | 612 | 0.060 |
Why?
|
| Neuritis | 1 | 2003 | 36 | 0.060 |
Why?
|
| Cell Survival | 2 | 2015 | 5882 | 0.060 |
Why?
|
| Cloning, Molecular | 4 | 1993 | 4320 | 0.060 |
Why?
|
| Species Specificity | 2 | 2022 | 2478 | 0.060 |
Why?
|
| Blotting, Southern | 3 | 2000 | 803 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2002 | 829 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2006 | 1723 | 0.060 |
Why?
|
| Nerve Endings | 1 | 2002 | 109 | 0.060 |
Why?
|
| Microscopy, Video | 1 | 2003 | 245 | 0.050 |
Why?
|
| Holoenzymes | 1 | 2002 | 41 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 3 | 2006 | 2765 | 0.050 |
Why?
|
| Perforin | 1 | 2023 | 168 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2012 | 2564 | 0.050 |
Why?
|
| Alphaherpesvirinae | 1 | 2021 | 10 | 0.050 |
Why?
|
| Complement C4 | 1 | 2002 | 257 | 0.050 |
Why?
|
| B-Lymphocytes | 3 | 2022 | 4665 | 0.050 |
Why?
|
| Serine | 2 | 1996 | 826 | 0.050 |
Why?
|
| Virus Shedding | 2 | 2014 | 108 | 0.050 |
Why?
|
| Protein Conformation | 3 | 2003 | 4011 | 0.050 |
Why?
|
| RNA | 1 | 2012 | 2749 | 0.050 |
Why?
|
| Lymphocyte Activation | 4 | 2011 | 5524 | 0.050 |
Why?
|
| Vesicular Stomatitis | 1 | 2021 | 16 | 0.050 |
Why?
|
| DNA, Recombinant | 3 | 2016 | 476 | 0.050 |
Why?
|
| Organic Cation Transporter 1 | 1 | 2021 | 11 | 0.050 |
Why?
|
| Point Mutation | 2 | 2005 | 1623 | 0.050 |
Why?
|
| Proline | 1 | 2003 | 458 | 0.050 |
Why?
|
| Ganglia, Sensory | 1 | 2000 | 20 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 959 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2010 | 1580 | 0.050 |
Why?
|
| Uridine | 1 | 2001 | 146 | 0.050 |
Why?
|
| Stromal Cells | 1 | 2006 | 1355 | 0.050 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2006 | 570 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2023 | 579 | 0.050 |
Why?
|
| Camelids, New World | 1 | 2020 | 20 | 0.050 |
Why?
|
| Molecular Weight | 6 | 1985 | 2255 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2017 | 63114 | 0.040 |
Why?
|
| Electrophoresis | 1 | 2000 | 240 | 0.040 |
Why?
|
| Gene Expression Profiling | 4 | 2022 | 9438 | 0.040 |
Why?
|
| Inflammation | 3 | 2022 | 10638 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2001 | 463 | 0.040 |
Why?
|
| Escherichia coli | 4 | 2016 | 4217 | 0.040 |
Why?
|
| Vaccines, Subunit | 1 | 2020 | 168 | 0.040 |
Why?
|
| DNA Primers | 3 | 2014 | 2892 | 0.040 |
Why?
|
| Kinetics | 5 | 2006 | 6473 | 0.040 |
Why?
|
| Leukocytes | 2 | 2004 | 2043 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 4328 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 2002 | 607 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7880 | 0.040 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 2019 | 31 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2018 | 71 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 1982 | 5021 | 0.040 |
Why?
|
| Policy Making | 1 | 2023 | 554 | 0.040 |
Why?
|
| Poly A | 1 | 1998 | 185 | 0.040 |
Why?
|
| Pandemics | 3 | 2023 | 8388 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2001 | 538 | 0.040 |
Why?
|
| Viridans Streptococci | 1 | 2017 | 15 | 0.040 |
Why?
|
| Influenza A virus | 1 | 2022 | 456 | 0.040 |
Why?
|
| STAT2 Transcription Factor | 1 | 2017 | 27 | 0.040 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2014 | 571 | 0.040 |
Why?
|
| Organophosphorus Compounds | 1 | 1979 | 215 | 0.040 |
Why?
|
| Nasal Mucosa | 1 | 2000 | 373 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2001 | 704 | 0.040 |
Why?
|
| Actins | 1 | 2005 | 2121 | 0.040 |
Why?
|
| Genomics | 1 | 2013 | 5720 | 0.040 |
Why?
|
| Gene Duplication | 1 | 2019 | 329 | 0.040 |
Why?
|
| Genitalia | 1 | 1998 | 112 | 0.040 |
Why?
|
| Cyclins | 1 | 2000 | 603 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2019 | 2726 | 0.040 |
Why?
|
| Immune Sera | 1 | 1997 | 641 | 0.040 |
Why?
|
| Axons | 1 | 2005 | 1684 | 0.040 |
Why?
|
| Bone Marrow Cells | 2 | 2003 | 2513 | 0.040 |
Why?
|
| Neoplasms | 2 | 2023 | 21683 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 9959 | 0.040 |
Why?
|
| Keratitis, Dendritic | 2 | 1986 | 35 | 0.040 |
Why?
|
| DNA Restriction Enzymes | 3 | 1984 | 570 | 0.040 |
Why?
|
| Acyclovir | 2 | 2005 | 272 | 0.040 |
Why?
|
| Asparagine | 1 | 2016 | 122 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 9734 | 0.040 |
Why?
|
| Chromosome Deletion | 3 | 1992 | 1401 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 713 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 5686 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 1979 | 435 | 0.030 |
Why?
|
| DNA, Single-Stranded | 2 | 1989 | 354 | 0.030 |
Why?
|
| Peptide Mapping | 1 | 1996 | 263 | 0.030 |
Why?
|
| Injections, Intravenous | 3 | 2003 | 1420 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 6314 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 1997 | 608 | 0.030 |
Why?
|
| S Phase | 1 | 1997 | 423 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 634 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2020 | 1792 | 0.030 |
Why?
|
| Autoantigens | 1 | 2020 | 892 | 0.030 |
Why?
|
| Interleukin-6 | 3 | 2005 | 3200 | 0.030 |
Why?
|
| Immunization, Passive | 1 | 1997 | 623 | 0.030 |
Why?
|
| Tranylcypromine | 1 | 2014 | 29 | 0.030 |
Why?
|
| Neurites | 1 | 2017 | 388 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2019 | 973 | 0.030 |
Why?
|
| RNA, Double-Stranded | 1 | 2016 | 290 | 0.030 |
Why?
|
| Models, Biological | 4 | 2010 | 9583 | 0.030 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1994 | 45 | 0.030 |
Why?
|
| Serine Proteases | 1 | 2014 | 52 | 0.030 |
Why?
|
| Immunity, Mucosal | 1 | 1998 | 490 | 0.030 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2014 | 88 | 0.030 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2014 | 158 | 0.030 |
Why?
|
| Cell Fractionation | 3 | 1982 | 252 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2023 | 1099 | 0.030 |
Why?
|
| Chimera | 2 | 2001 | 485 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2024 | 2421 | 0.030 |
Why?
|
| Acute Disease | 2 | 2019 | 7149 | 0.030 |
Why?
|
| Stilbamidines | 1 | 1994 | 44 | 0.030 |
Why?
|
| Telomere-Binding Proteins | 1 | 2014 | 116 | 0.030 |
Why?
|
| RNA Probes | 1 | 1993 | 113 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 7181 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2019 | 1076 | 0.030 |
Why?
|
| Morbidity | 1 | 2019 | 1769 | 0.030 |
Why?
|
| HMGB2 Protein | 1 | 2012 | 6 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 1994 | 425 | 0.030 |
Why?
|
| Radiation Chimera | 2 | 2003 | 223 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 2017 | 638 | 0.030 |
Why?
|
| HIV Infections | 1 | 2019 | 16718 | 0.030 |
Why?
|
| Protein Transport | 2 | 2011 | 1988 | 0.030 |
Why?
|
| Mice, SCID | 3 | 2008 | 2716 | 0.030 |
Why?
|
| Chromosome Aberrations | 2 | 2014 | 1813 | 0.030 |
Why?
|
| Chaperonins | 1 | 2012 | 62 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1993 | 154 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2014 | 798 | 0.030 |
Why?
|
| Spleen | 3 | 2008 | 2362 | 0.030 |
Why?
|
| Immunoglobulin Class Switching | 1 | 1994 | 291 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2014 | 321 | 0.030 |
Why?
|
| Restriction Mapping | 2 | 1989 | 878 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 1988 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 2 | 1989 | 862 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3557 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 708 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2015 | 1369 | 0.030 |
Why?
|
| trans-Golgi Network | 1 | 2011 | 33 | 0.030 |
Why?
|
| Macrophages, Peritoneal | 1 | 2012 | 251 | 0.030 |
Why?
|
| Genes, pol | 1 | 1991 | 51 | 0.020 |
Why?
|
| Necrosis | 1 | 2015 | 1643 | 0.020 |
Why?
|
| Endosomes | 1 | 2014 | 520 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2014 | 453 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1996 | 1227 | 0.020 |
Why?
|
| DNA Polymerase II | 1 | 1991 | 107 | 0.020 |
Why?
|
| Bacteremia | 1 | 2017 | 962 | 0.020 |
Why?
|
| Recurrence | 2 | 2014 | 8340 | 0.020 |
Why?
|
| Proteolipids | 1 | 2010 | 117 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2003 | 4751 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 2025 | 0.020 |
Why?
|
| Condoms | 1 | 2012 | 323 | 0.020 |
Why?
|
| Chickens | 1 | 1992 | 865 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 434 | 0.020 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2010 | 132 | 0.020 |
Why?
|
| Myelin Proteins | 1 | 2010 | 215 | 0.020 |
Why?
|
| Cytosol | 1 | 2012 | 901 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1655 | 0.020 |
Why?
|
| Surface Properties | 1 | 2012 | 1184 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2017 | 1226 | 0.020 |
Why?
|
| Fungi | 1 | 2012 | 327 | 0.020 |
Why?
|
| Encephalitis | 1 | 2012 | 423 | 0.020 |
Why?
|
| Ribonucleosides | 1 | 2009 | 82 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1988 | 222 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 1993 | 3129 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 1988 | 322 | 0.020 |
Why?
|
| Luciferases | 1 | 2010 | 733 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 4 | 1978 | 1144 | 0.020 |
Why?
|
| Carrier State | 1 | 2011 | 518 | 0.020 |
Why?
|
| Immunohistochemistry | 4 | 2006 | 11366 | 0.020 |
Why?
|
| Acetyltransferases | 1 | 1988 | 234 | 0.020 |
Why?
|
| Virus Attachment | 1 | 2007 | 55 | 0.020 |
Why?
|
| Genotype | 2 | 2018 | 12951 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 720 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 1701 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1988 | 1454 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2005 | 150 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 2006 | 406 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 1375 | 0.020 |
Why?
|
| Haplorhini | 2 | 1983 | 552 | 0.020 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1984 | 31 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2010 | 1028 | 0.020 |
Why?
|
| Anxiety | 1 | 2019 | 4297 | 0.020 |
Why?
|
| Genes, Essential | 1 | 2005 | 183 | 0.020 |
Why?
|
| Autoradiography | 2 | 1975 | 745 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1985 | 1157 | 0.010 |
Why?
|
| Antibody-Producing Cells | 1 | 2003 | 143 | 0.010 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2003 | 53 | 0.010 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2005 | 212 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2009 | 850 | 0.010 |
Why?
|
| Complement Inactivator Proteins | 1 | 2003 | 79 | 0.010 |
Why?
|
| Estrus | 1 | 2003 | 81 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1994 | 1622 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 3586 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 2002 | 77 | 0.010 |
Why?
|
| Virus Internalization | 1 | 2007 | 501 | 0.010 |
Why?
|
| Reassortant Viruses | 1 | 2002 | 37 | 0.010 |
Why?
|
| Lung | 1 | 2022 | 9856 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1982 | 156 | 0.010 |
Why?
|
| Phenylacetates | 1 | 2002 | 114 | 0.010 |
Why?
|
| Haptens | 1 | 2002 | 166 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1982 | 518 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 1983 | 229 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2012 | 2455 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 2003 | 457 | 0.010 |
Why?
|
| Nitrophenols | 1 | 2002 | 172 | 0.010 |
Why?
|
| Langerhans Cells | 1 | 2003 | 173 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 2012 | 1732 | 0.010 |
Why?
|
| Endodeoxyribonucleases | 1 | 1983 | 165 | 0.010 |
Why?
|
| Detergents | 1 | 1982 | 230 | 0.010 |
Why?
|
| Cysteine | 1 | 2006 | 874 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 2005 | 590 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 1889 | 0.010 |
Why?
|
| Lymphopenia | 1 | 2003 | 285 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1988 | 1341 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2004 | 617 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 3462 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 1982 | 214 | 0.010 |
Why?
|
| Cell Movement | 2 | 2003 | 5217 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 1791 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 565 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2002 | 844 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2015 | 10481 | 0.010 |
Why?
|
| Adult | 3 | 2022 | 214055 | 0.010 |
Why?
|
| Introns | 1 | 2002 | 991 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 2003 | 673 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2002 | 1866 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1993 | 9274 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9727 | 0.010 |
Why?
|
| Lymph Nodes | 2 | 2003 | 3474 | 0.010 |
Why?
|
| Retroviridae | 1 | 1982 | 914 | 0.010 |
Why?
|
| Cross Reactions | 1 | 2001 | 841 | 0.010 |
Why?
|
| Diploidy | 1 | 1978 | 138 | 0.010 |
Why?
|
| Cell-Free System | 2 | 1977 | 344 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2001 | 659 | 0.010 |
Why?
|
| Endocytosis | 1 | 2002 | 985 | 0.010 |
Why?
|
| Kidney | 2 | 1984 | 7186 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2003 | 2242 | 0.010 |
Why?
|
| Pregnancy | 1 | 2019 | 29144 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1994 | 8949 | 0.010 |
Why?
|
| Sialic Acids | 1 | 1977 | 127 | 0.010 |
Why?
|
| Age Factors | 2 | 2005 | 18370 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 1982 | 1041 | 0.010 |
Why?
|
| Carcinoma, Krebs 2 | 1 | 1975 | 8 | 0.010 |
Why?
|
| Polynucleotides | 1 | 1975 | 35 | 0.010 |
Why?
|
| Immunocompetence | 1 | 1996 | 137 | 0.010 |
Why?
|
| Centrifugation, Zonal | 1 | 1975 | 14 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1996 | 330 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1975 | 116 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1975 | 104 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1975 | 223 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2002 | 3913 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3920 | 0.010 |
Why?
|
| Ficusin | 1 | 1994 | 15 | 0.010 |
Why?
|
| Trypsin | 1 | 1975 | 511 | 0.010 |
Why?
|
| Galactosides | 1 | 1994 | 52 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 19905 | 0.010 |
Why?
|
| Child | 1 | 2022 | 77709 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1978 | 1154 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2005 | 25625 | 0.010 |
Why?
|
| Immunoglobulins | 2 | 1986 | 881 | 0.010 |
Why?
|
| Methionine | 1 | 1975 | 590 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1975 | 572 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1982 | 2942 | 0.010 |
Why?
|
| Cricetinae | 1 | 1975 | 2472 | 0.010 |
Why?
|
| Genetic Linkage | 2 | 1986 | 2421 | 0.010 |
Why?
|
| Ovary | 1 | 1975 | 981 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 1085 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 4149 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 4420 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2001 | 2133 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 163280 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 213383 | 0.000 |
Why?
|
| Up-Regulation | 1 | 1996 | 4217 | 0.000 |
Why?
|
| Mice, Inbred A | 1 | 1986 | 248 | 0.000 |
Why?
|
| Adenoviruses, Human | 1 | 1988 | 257 | 0.000 |
Why?
|
| H-2 Antigens | 1 | 1986 | 366 | 0.000 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 1917 | 0.000 |
Why?
|
| Brain | 1 | 2012 | 26385 | 0.000 |
Why?
|
| Indoles | 1 | 1994 | 1839 | 0.000 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1994 | 2455 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 8863 | 0.000 |
Why?
|
| Cell Division | 1 | 1989 | 4568 | 0.000 |
Why?
|
| Hydroxylamines | 1 | 1981 | 40 | 0.000 |
Why?
|
| Rats | 1 | 1996 | 24260 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 17446 | 0.000 |
Why?
|
| DNA, Circular | 1 | 1979 | 97 | 0.000 |
Why?
|
| Polyribosomes | 1 | 1977 | 110 | 0.000 |
Why?
|
| Intracellular Membranes | 1 | 1977 | 390 | 0.000 |
Why?
|
| Nucleic Acid Conformation | 1 | 1979 | 913 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1981 | 4740 | 0.000 |
Why?
|